Table 8Clinical evidence summary: Community pharmacist based within a community pharmacy

OutcomesNo of Participants (studies) Follow upQuality of the evidence (GRADE)Relative effect (95% CI)Anticipated absolute effects
Risk with ControlRisk difference with Community pharmacist @ pharmacy versus usual care (95% CI)
Mortality

2989

(6 studies)

6 months

⊕⊝⊝⊝

VERY LOWa,b,c

due to risk of bias, inconsistency, imprecision

RR 0.69 (0.46 to 1.02)Moderate
32 per 1000

10 fewer per 1000

(from 17 fewer to 1 more)

ED presentations

2413

(7 studies)

3 months

⊕⊝⊝⊝

LOWa,c

due to risk of bias, imprecision

RR 0.63 (0.53 to 0.76)Moderate
93 per 1000

34 fewer per 1000

(from 22 fewer to 44 fewer)

ED presentations

314

(1 study)

12 months

⊕⊕⊝⊝

LOWa

due to risk of bias

The mean ED presentations in the control groups was

2.68 days

The mean ED presentations in the intervention groups was

0.52 lower

(1.43 lower to 0.39 higher)

Hospital admissions

1267

(7 studies)

3 months

⊕⊝⊝⊝

VERY LOWa,b,c

due to risk of bias, inconsistency, imprecision

RR 0.92 (0.56 to 1.49)Moderate
93 per 1000

7 fewer per 1000

(from 41 fewer to 46 more)

Mean number of hospitalisations

1612

(2 study)

6-12 months

⊕⊕⊕⊝

MODERATEa

due to risk of bias

The mean number of hospitalisations in the control groups was

0.08 admissions

The mean number of hospitalisations in the intervention groups was

0.02 lower

(0.05 lower to 0.1 higher)

GP visits

330

(2 studies)

2-3 months

⊕⊝⊝⊝

VERY LOWa,b,c

due to risk of bias, inconsistency, imprecision

RR 0.6 (0.17 to 2.06)Moderate
797 per 1000

319 fewer per 1000

(from 662 fewer to 845 more)

(a)

Downgraded by 1 increment if the majority of the evidence was at high risk of bias, and downgraded by 2 increments if the majority of the evidence was at very high risk of bias.

(b)

Downgraded by 1 or 2 increments because: the point estimate varies widely across studies, unexplained by subgroup analysis.

(c)

Downgraded by 1 increment if the confidence interval crossed 1 MID or by 2 increments if the confidence interval crossed both MIDs.

From: Chapter 10, Community-based pharmacists

Cover of Emergency and acute medical care in over 16s: service delivery and organisation
Emergency and acute medical care in over 16s: service delivery and organisation.
NICE Guideline, No. 94.
National Guideline Centre (UK).
Copyright © NICE 2018.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.